SCHEMBL12528160

SCHEMBL12528160

Cc1cc(C)c2nc(-c3cc(C)nn3-c3ncccc3Cl)oc(=O)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ SLC40A1 Q9NP59 1/20 0.34
▸ CYP17A1 P05093 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ DHODH Q02127 1/20 0.34
▸ PHGDH O43175 1/20 0.32
▸ PARP1 P09874 1/20 0.32
▸ PARP4 Q9UKK3 1/20 0.32
▸ TRPV1 Q8NER1 3/20 0.32
▸ PIK3CD O00329 1/20 0.31
▸ PIK3CA P42336 1/20 0.31
▸ PIK3CB P42338 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ PBRM1 Q86U86 1/20 0.31
▸ ELANE P08246 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12528235 0.93 DHODH (0.33) SLC40A1CYP17A1CYP1A2DHODHPHGDH
SCHEMBL950938 0.92 CYP17A1 (0.34) SMN1; SMN2CYP17A1CYP1A2DHODHTRPV1
SCHEMBL12528553 0.90 DHODH (0.35) SLC40A1CYP17A1CYP1A2DHODHPARP1
SCHEMBL12528168 0.90 DHODH (0.43) SLC40A1CYP17A1CYP1A2DHODHPARP1
SCHEMBL12528224 0.90 C1R (0.34) CYP17A1CYP1A2DHODHPHGDHTRPV1
SCHEMBL12528215 0.90 DHODH (0.35) RAB9ACYP17A1CYP1A2DHODHPHGDH
SCHEMBL12912129 0.90 DHODH (0.33) RAB9ASLC40A1CYP17A1CYP1A2DHODH
SCHEMBL12528926 0.89 DHODH (0.33) SLC40A1CYP17A1CYP1A2DHODHPARP1
SCHEMBL12528180 0.88 CYP17A1 (0.37) SLC40A1CYP17A1CYP1A2DHODHPHGDH
SCHEMBL12528568 0.88 MEN1 (0.34) RAB9ASLC40A1CYP17A1CYP1A2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7968573-B2 Hydrazide compound and pesticidal use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-28 — — US disclosed
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME IKEGAMI HIROSHI 2011-03-24 — — US disclosed
US-7867949-B2 Hydrazide compound and pesticidal use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-01-11 — — US disclosed
US-20090181956-A1 Hydrazide Compound and Pesticidal Use of the Same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071291-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME ACHE, H1-2, H1-0 RAB9A 391/4885SMN1; SMN2 2851/4885SLC40A1 2101/4885
US-20090181956-A1 Hydrazide Compound and Pesticidal Use of the Same ACHE, DDT, CAT RAB9A 523/4885SMN1; SMN2 2755/4885SLC40A1 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback